Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A New Red Flag Classification to Predict Vasovagal Event During Office Hysteroscopy: A Prospective Feasibility Study

NCT07030218 is registered in ClinicalTrials.gov with Tanvir Hospital as lead sponsor.

NCT NCT07030218
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07030218 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A New Red Flag Classification to Predict Vasovagal Event During Office Hysteroscopy: A Prospective Feasibility Study
Lead sponsor
Tanvir Hospital
Phase
Observational
Overall status
Active, not recruiting
Start date
June 20, 2025
Completion date
July 12, 2026
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

presyncope, vasovagal syncope (vvs)